HomeCompareSGCPF vs MRK

SGCPF vs MRK: Dividend Comparison 2026

SGCPF yields 3992.02% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SGCPF wins by $7038408636820.28M in total portfolio value
10 years
SGCPF
SGCPF
● Live price
3992.02%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7038408636820.33M
Annual income
$6,707,864,260,492,553,000.00
Full SGCPF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SGCPF vs MRK

📍 SGCPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSGCPFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SGCPF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SGCPF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SGCPF
Annual income on $10K today (after 15% tax)
$339,321.36/yr
After 10yr DRIP, annual income (after tax)
$5,701,684,621,418,670,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SGCPF beats the other by $5,701,684,621,418,662,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SGCPF + MRK for your $10,000?

SGCPF: 50%MRK: 50%
100% MRK50/50100% SGCPF
Portfolio after 10yr
$3519204318410.19M
Annual income
$3,353,932,130,246,281,700.00/yr
Blended yield
95.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SGCPF
No analyst data
Altman Z
10.6
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SGCPF buys
0
MRK buys
0
No recent congressional trades found for SGCPF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSGCPFMRK
Forward yield3992.02%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$7038408636820.33M$56.8K
Annual income after 10y$6,707,864,260,492,553,000.00$9,798.13
Total dividends collected$7015858891478.01M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SGCPF vs MRK ($10,000, DRIP)

YearSGCPF PortfolioSGCPF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$409,902$399,201.60$11,206$366.19+$398.7KSGCPF
2$15,731,433$15,292,838.50$12,650$502.35+$15.72MSGCPF
3$565,353,313$548,520,679.36$14,407$694.19+$565.34MSGCPF
4$19,027,950,361$18,423,022,315.76$16,585$967.82+$19027.93MSGCPF
5$599,854,207,291$579,494,300,405.11$19,342$1,363.89+$599854.19MSGCPF
6$17,715,207,654,637$17,073,363,652,836.21$22,913$1,947.19+$17715207.63MSGCPF
7$490,188,440,412,516$471,233,168,222,053.44$27,662$2,823.89+$490188440.38MSGCPF
8$12,710,718,187,796,452$12,186,216,556,555,060.00$34,159$4,173.35+$12710718187.76MSGCPF
9$308,919,977,876,429,600$295,319,509,415,487,360.00$43,337$6,308.80+$308919977876.39MSGCPF
10$7,038,408,636,820,333,000$6,707,864,260,492,553,000.00$56,776$9,798.13+$7038408636820.28MSGCPF

SGCPF vs MRK: Complete Analysis 2026

SGCPFStock

Solstice Gold Corp. engages in the exploration for and development of mineral resource properties in Ontario and Nunavut, Canada. It primarily explores for gold deposits. The company holds a 100% interest in the Kahuna gold project covering an area of 866 square kilometers located in Nunavut, as well as secondary rights covering an adjacent 683 square kilometres. It also has an option agreement to acquire a 100% interest in the Red Lake Extension project consisting of 10 claims located in the northern part of the Red Lake Gold District. The company was formerly known as Dunnedin Gold Inc. and changed its name to Solstice Gold Corp. in September 2017. Solstice Gold Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Full SGCPF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SGCPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SGCPF vs SCHDSGCPF vs JEPISGCPF vs OSGCPF vs KOSGCPF vs MAINSGCPF vs JNJSGCPF vs ABBVSGCPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.